Ann Dahlberg

1.3k total citations · 1 hit paper
35 papers, 858 citations indexed

About

Ann Dahlberg is a scholar working on Hematology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Ann Dahlberg has authored 35 papers receiving a total of 858 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hematology, 12 papers in Oncology and 9 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Ann Dahlberg's work include Hematopoietic Stem Cell Transplantation (20 papers), Acute Lymphoblastic Leukemia research (9 papers) and Acute Myeloid Leukemia Research (8 papers). Ann Dahlberg is often cited by papers focused on Hematopoietic Stem Cell Transplantation (20 papers), Acute Lymphoblastic Leukemia research (9 papers) and Acute Myeloid Leukemia Research (8 papers). Ann Dahlberg collaborates with scholars based in United States, Italy and South Africa. Ann Dahlberg's co-authors include Colleen Delaney, Irwin D. Bernstein, Filippo Milano, Frederick R. Appelbaum, Rachel B. Salit, Ann E. Woolfrey, Ted Gooley, Effie W. Petersdorf, Mary E.D. Flowers and Brent L. Wood and has published in prestigious journals such as New England Journal of Medicine, Blood and Clinical Infectious Diseases.

In The Last Decade

Ann Dahlberg

33 papers receiving 849 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cord-Blood Transplantation in Patients with Minimal Residual Disease

2016 284 citations Filippo Milano, Ted Gooley et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Ann Dahlberg

Since Specialization

Citations

This map shows the geographic impact of Ann Dahlberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann Dahlberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann Dahlberg more than expected).

Fields of papers citing papers by Ann Dahlberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann Dahlberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann Dahlberg. The network helps show where Ann Dahlberg may publish in the future.

Co-authorship network of co-authors of Ann Dahlberg

This figure shows the co-authorship network connecting the top 25 collaborators of Ann Dahlberg. A scholar is included among the top collaborators of Ann Dahlberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann Dahlberg. Ann Dahlberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Long-term outcomes and quality of life with treosulfan-based conditioning in hematological malignancies 2025 ·Blood Advances ·Rohtesh S. Mehta, Stephanie J. Lee, Ted Gooley, (unknown), Ann Dahlberg, Colleen Delaney, Boglarka Gyurkocza, (unknown), H. Joachim Deeg, Filippo Milano	0
2	Dilanubicel, a Non-HLA-Matched Pooled Universal Product, Transforming Single Cord Blood Transplantation Success Rates 2024 ·Blood ·Filippo Milano, Ann Dahlberg, (unknown), (unknown), (unknown), (unknown), Brandon Hadland, Francesco Mazziotta, Colleen Delaney	1
3	Decreasing chronic graft-versus-host disease rates in all populations 2024 ·Blood Advances ·Paul A. Carpenter, Theodore A. Gooley, (unknown), Catherine J. Lee, Lauri Burroughs, Rohtesh S. Mehta, Rachel B. Salit, Neel S. Bhatt, Elizabeth F. Krakow, Ann Dahlberg, Albert C. Yeh, Corinne Summers, Masumi Ueda, Effie W. Petersdorf, (unknown), Laura Connelly‐Smith, Stephanie J. Lee	6
4	Acute kidney injury and chronic kidney disease in umbilical cord blood transplant recipients 2023 ·Frontiers in Oncology ·(unknown), Elisabetta Xue, (unknown), (unknown), (unknown), Ann Dahlberg, (unknown), (unknown), (unknown), Ted Gooley, Sangeeta Hingorani, Filippo Milano	2
5	Incidence of venous thromboembolic events not related to vascular catheters in a prospective cohort of critically ill children 2022 ·European Journal of Pediatrics ·(unknown), Urban Fläring, Peter Larsson, Sylvie Kaiser, (unknown), Tony Frisk, Ann Dahlberg, (unknown), Åke Norberg, (unknown)	1
6	Hematopoietic Cell Transplantation after CD19 Chimeric Antigen Receptor T Cell-Induced Acute Lymphoblastic Leukemia Remission Confers a Leukemia-Free Survival Advantage 2021 ·Transplantation and Cellular Therapy ·Corinne Summers, Qian Wu, Colleen Annesley, Marie Bleakley, Ann Dahlberg, (unknown), Wenjun Huang, Jenna Voutsinas, Adam Brand, Wendy M. Leisenring, Michael C. Jensen, Julie R. Park, Rebecca Gardner	44
7	Guidelines for Pediatric Unrelated Cord Blood Transplantation—Unique Considerations 2021 ·Transplantation and Cellular Therapy ·Ann Dahlberg, Joanne Kurtzberg, Jaap Jan Boelens, Caridad Martinez, Paul A. Carpenter, Priti Tewari	5
8	T-Receptor Excisional Circle (TREC) Levels Are Associated with OS, NRM and Relapse in Cord Blood Transplant (CBT) Patients 2021 ·Transplantation and Cellular Therapy ·Ann Dahlberg, (unknown), Colleen Delaney, Rachel B. Salit, Mary W. Redman, (unknown), Kelsey K. Baker, Filippo Milano	1
9	Impact of T Cell Repertoire Diversity on Mortality Following Cord Blood Transplantation 2020 ·Frontiers in Oncology ·Filippo Milano, Ryan Emerson, Rachel B. Salit, Katherine A. Guthrie, (unknown), Ann Dahlberg, Harlan Robins, Colleen Delaney	3
10	Clinical Experience of Tabelecleucel in Patients with Life-Threatening Complications of Epstein-Barr Virus Viremia 2020 ·Blood ·Lilibeth Torno, Ann Dahlberg, Armin Ghobadi, Patrick J. Stiff, Ran Reshef, (unknown), Willis H. Navarro, Laurence Gamelin, Rajani Dinavahi, (unknown), Norma Guzmán‐Becerra, Susan E. Prockop	2
11	High Incidence of Herpes Zoster After Cord Blood Hematopoietic Cell Transplant Despite Longer Duration of Antiviral Prophylaxis 2020 ·Clinical Infectious Diseases ·Elisabetta Xue, Hu Xie, Wendy M. Leisenring, Louise E. Kimball, Sonia Goyal, E Chung, (unknown), (unknown), A. S. Edwards, Ann Dahlberg, Rachel B. Salit, Colleen Delaney, Steven A. Pergam, Michael Boeckh, Filippo Milano, Joshua A. Hill	10
12	Incidence of and risk factors for venous thrombosis in children with percutaneous non-tunnelled central venous catheters 2019 ·British Journal of Anaesthesia ·(unknown), Urban Fläring, Åke Norberg, Ann Dahlberg, (unknown), Sylvie Kaiser, (unknown), Anna Svenningsson, Tony Frisk, Peter Larsson, (unknown)	31
13	Prognosis of relapse after hematopoietic cell transplant (HCT) for treatment of leukemia or myelodysplastic syndrome (MDS) in children 2019 ·Bone Marrow Transplantation ·Ann Dahlberg, Wendy M. Leisenring, Marie Bleakley, Soheil Meshinchi, K. Scott Baker, Corinne Summers, Brandon Hadland, Colleen Delaney, Kanwaldeep Mallhi, Lauri M. Burroughs, Paul A. Carpenter, Ann E. Woolfrey	17
14	Risk Factors for Subsequent Central Nervous System Tumors in Pediatric Allogeneic Hematopoietic Cell Transplant: A Study from the Center for International Blood and Marrow Transplant Research (CIBMTR) 2017 ·Biology of Blood and Marrow Transplantation ·Melissa Gabriel, Bronwen E. Shaw, Ruta Brazauskas, Min Chen, David A. Margolis, Henrik Sengeløv, Ann Dahlberg, Ibrahim Ahmed, David Delgado, Hillard M. Lazarus, Brenda Gibson, Kasiani C. Myers, Rammurti T. Kamble, Aly Abdel‐Mageed, Chi Kong Li, Mary E.D. Flowers, Minoo Battiwalla, Bipin N. Savani, Navneet S. Majhail, Peter J. Shaw	5
15	Cord blood transplantation: rewind to fast forward 2016 ·Bone Marrow Transplantation ·Ann Dahlberg, Filippo Milano	13
16	Cord-Blood Transplantation in Patients with Minimal Residual Disease breakdown → 2016 ·New England Journal of Medicine ·Filippo Milano, Ted Gooley, Brent L. Wood, Ann E. Woolfrey, Mary E.D. Flowers, K Doney, Robert P. Witherspoon, Marco Mielcarek, Joachim Deeg, Mohamed L. Sorror, Ann Dahlberg, Brenda M. Sandmaier, Rachel B. Salit, Effie W. Petersdorf, Frederick R. Appelbaum, Colleen Delaney	284
17	Infusion of a non-HLA-matched ex-vivo expanded cord blood progenitor cell product after intensive acute myeloid leukaemia chemotherapy: a phase 1 trial 2016 ·The Lancet Haematology ·Colleen Delaney, Filippo Milano, Laura Cicconi, Megan Othus, Pamela S. Becker, Vicky Sandhu, Ian B. Nicoud, Ann Dahlberg, Irwin D. Bernstein, Frederick R. Appelbaum, Elihu H. Estey	26
18	Notch-mediated expansion of cord blood progenitors: maintenance of transcriptional and epigenetic fidelity 2015 ·Leukemia ·Ann Dahlberg, Sukyung Woo, Colleen Delaney, Peter Boyle, Andreas Gnirke, Christoph Bock, B Bernstein, Alexander Meissner, Raphaël Gottardo, Irwin D. Bernstein	8
19	Infusion of Ex Vivo Expanded Cord Blood Progenitor Cells Reduces the Risk of Bacteremia after Myeloablative Cord Blood Transplant 2014 ·Blood ·Corinne Summers, Filippo Milano, Ted Gooley, Ann Dahlberg, Colleen Delaney	4
20	Ex vivo expansion of human hematopoietic stem and progenitor cells 2011 ·Blood ·Ann Dahlberg, Colleen Delaney, Irwin D. Bernstein	203

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact